Soleno Therapeutics | 4:持股变动声明-董事 MARIO ERNEST
Soleno Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Vivo Opportunity Fund Holdings, L.P.(22.5%),Vivo Opportunity, LLC(22.5%)
Soleno Therapeutics | 4:持股变动声明-股东 Vivo Opportunity, LLC
Soleno Therapeutics | 3:首次持股声明-高管 Manning Meredith
Soleno Therapeutics | 3:首次持股声明-高管 Huang Michael F.
Soleno Therapeutics | 4:持股变动声明-高管 Yen Kristen
Soleno Therapeutics | 4:持股变动声明-高管 Mackaness James H
Soleno Therapeutics | 4:持股变动声明-高管 Hirano Patricia C
Soleno Therapeutics | 4:持股变动声明-高管 Anish Bhatnagar
Soleno Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(2.3%),Commodore Capital Master LP(2.3%)
Soleno Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
Soleno Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(8.3%),Janus Henderson Biotech Innovation Master Fund Ltd(2.7%)
Soleno Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Adage Capital Partners, L.P.(5.99%),Adage Capital Partners GP, L.L.C.(5.99%)等
Soleno Therapeutics | 4:持股变动声明-高管 Yen Kristen
Soleno Therapeutics | 4:持股变动声明-高管 Hirano Patricia C
Soleno Therapeutics | 4:持股变动声明-高管 Anish Bhatnagar
Soleno Therapeutics | 4:持股变动声明-董事 MARIO ERNEST
Soleno Therapeutics | 4:持股变动声明-高管 Yen Kristen
Soleno Therapeutics | 4:持股变动声明-高管 Mackaness James H
Soleno Therapeutics | 4:持股变动声明-高管 Hirano Patricia C
暂无数据